Plante Moran Financial Advisors, LLC Clovis Oncology, Inc. Transaction History

Plante Moran Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 29, 2019	SELL	$11.63 - $32.67 $662 - $1,862	-57 Closed	0 $0
Q2 2018 Jul 26, 2018	SELL	$42.06 - $62.4 $2,902 - $4,305	-69 Reduced 54.76%	57 $3,000
Q1 2018 May 01, 2018	BUY	$50.12 - $67.72 $3,107 - $4,198	62 Added 96.88%	126 $7,000
Q4 2017 Feb 01, 2018	BUY	$57.69 - $84.58 $403 - $592	7 Added 12.28%	64 $4,000
Q3 2017 Nov 08, 2017	BUY	$67.17 - $84.81 $3,828 - $4,834	57	57 $5,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.